Cystic Fibrosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You can be male or female
- You must be 18 years old or older
- You have been diagnosed with cystic fibrosis
- You are receiving care at the CRCM centre in Lille or Créteil (France)
- You are currently being treated with a medication called ETI (confirm with trial site for full name)
- You are covered by social security
- You are able to understand what the study involves, sign a consent form agreeing to take part, and follow the study's procedures for collecting information
Who may not be able to join:
- You have a medical reason that means you cannot safely do a physical stress/exercise test, either absolutely or under certain conditions (confirm with trial site)
- You have had a flare-up or worsening of your cystic fibrosis symptoms in the 4 weeks before your first study visit
- You are currently pregnant or breastfeeding
- There are administrative reasons that prevent your participation (confirm with trial site)
- You are currently in prison or otherwise legally deprived of your freedom
- You are under 18 or are an adult who is legally protected (for example, under guardianship)
- You are unable or unwilling to give your written consent to take part
- You are in an emergency medical situation at the time of enrolment
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +33 3.20.44.41.45
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Estimate the prevalence of ventilatory limitation measured by a portable spirometer during a submaximal exercise test (6-minute walk test) in patients with cystic fibrosis undergoing ETI.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.